Literature DB >> 15246776

Development of a highly sensitive and specific new testosterone time-resolved fluoroimmunoassay in human serum.

Jean Fiet1, Frank Giton, Ibrahim Fidaa, Alain Valleix, Hervé Galons, Jean-Pierre Raynaud.   

Abstract

A new time-resolved fluoroimmunoassay (TR-FIA) of testosterone in serum is described, using a biotinylated testosterone tracer, with a long spacer arm between biotin and testosterone, coupled to the C3 of the testosterone: a biotinylaminodecane carboxymethyloxime testosterone. This tracer affords a great sensitivity of the standard curve, because a amount of 0.3 pg of testosterone can be significantly measured on the testosterone standard curve. The "functional" sensitivity is at least equal to 21 pg/ml of serum. The specificity of the assay is insured by a celite chromatographic step on new minicolumns before immunoassay. The variation coefficient of inter-series reproducibility measured on low and normal testosterone levels in untreated and testosterone treated hypogonadal men were between 2.17 and 5.07%. The accuracy test, (overload and dilution tests) gave satisfying results. Moreover, in a comparison with GCMS, it appeared that the correlation coefficient was 0.992 and no significant difference could be exhibited between the two methods. Consequently, this specific, sensitive reproducible and easy to use method is well suited to the measurement of testosterone in clinical and pharmacological conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246776     DOI: 10.1016/j.steroids.2004.04.008

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  4 in total

1.  Assessment of urinary total testosterone production by a highly sensitive time-resolved fluorescence immunoassay.

Authors:  Shihua Bao; Yifeng Peng; Shile Sheng; Qide Lin
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

2.  Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading.

Authors:  A Pichon; Y Neuzillet; H Botto; J-P Raynaud; C Radulescu; V Molinié; J-M Herve; T Lebret
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-10-06       Impact factor: 5.554

3.  Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.

Authors:  Shi Le Sheng; Qing Wang; Gang Huang; Bin Yu; Wen Xin Qin
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

4.  Development of time-resolved immunofluorometric assays for vascular endothelial growth factor and application on plasma of patients with gastric tumours.

Authors:  S L Sheng; S H Bao; G Huang; L M Wang
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.